An official coronavirus-linked death toll is continuing to rise in Tajikistan.
According to data from the Ministry of Health and Social Protection of the Population (MoHSPP), two more coronavirus-linked deaths have been officially confirmed in Tajikistan as of the evening of July 14 bringing a total number of the coronavirus-related deaths that have been officially registered in the country since June 21, 2021 to nineteen.
Thus, a total number of the officially confirmed coronavirus-linked deaths in Tajikistan has reached 109 since April 30, 2020, when the infection index cases were officially confirmed in Dushanbe and Khujand.
47 new cases of the novel coronavirus (COVID-19) have been officially confirmed in Tajikistan as of the evening of July 14, bringing a total number of COVID-19 cases officially reported in the country since June 21 to 597.
It is the highest daily number of coronavirus cases officially confirmed in the country since June 21, 2021.
The total number of the officially confirmed cases of COVID-19 infection in Tajikistan has reached 13,958 since April 30, 2020, when its index cases were confirmed in the country.
A MoHSPP says nineteen COVID-19 patients recovered in the country yesterday, bringing a total number of those who have been cured in Tajikistan since April 30, 2020 to 13,600 (99 percent).
Meanwhile, according to unofficial data, the number of affected persons and deaths is in the thousands.
The COVID-19 pandemic in Tajikistan is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have spread to Tajikistan when its index cases, in Dushanbe and Khujand, were confirmed on 30 April 2020.
The First Deputy Minister of Health, Ghafour Muhsinzoda, on July 13 held a meeting with representatives of the Chinese company Sinovac Biotech, which developed an inactivated virus COVID-19 vaccine CoronaVac, through video conferencing.. The parties reportedly discussed issues related to procurement and the next delivery of the required doses of the vaccine to Tajikistan.
CoronaVac, also known as the Sinovac COVID-19 vaccine, relies on traditional technology similar to BBIBP-CorV and Covaxin, other inactivated-virus COVID-19 vaccines. CoronaVac does not need to be frozen and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8°C, temperatures at which flu vaccines are kept.
The coronavirus COVID-19 is reportedly affecting 220 countries and territories. According to COVID-19 data provided by Worldometer, coronavirus cases around the globe have been reported at 189,178,283 since China reported its first cases to the World Health Organization (WHO) in December 2019. Of them, 172,805,144 have recovered and 4,074,555 have died.
